What's breaking now, across thousands of outlets.
(RTTNews) - AstraZeneca (AZN) said Tuesday that full results from the Phase 3 CROSSING trial showed Tezspire improved disease remission and swallowing symptoms in adolescents and adults with eosinophilic esophagitis.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
News Provided by Market Updates on behalf of Western Star Resources Inc. VANCOUVER, British Columbia, Oct. 20, 2026 (GLOBE NEWSWIRE) — Market Updates News Commentary – Prices for major tungsten…
Done, a group of companies, has started operating in Türkiye, a market that recorded approximately $365.4 billion in imports in 2025 where 41.8% of SMEs remain partially or fully credit-constrained…
AUSTIN, Texas, Oct. 20, 2026 (GLOBE NEWSWIRE) — AINewsWire Editorial Coverage: Experimentation is giving way to commitment as Wall Street’s biggest firms embrace blockchain.
The U.S. imposed tariffs of up to 50% on most Indian goods in August 2025 after trade talks broke down
Key PointsThe Dogecoin cryptocurrency was created as a joke, so it wasn't designed with any particular use-case in mind.
Key PointsThe Vanguard Information Technology ETF has high exposure to the top stocks, many of which are overvalued.
